11.07.2018

Bayer extends smallholder farmer support beyond Eastern Cape to KwaZulu Natal

- Partnership with local government delivers farming equipment to communal farmers in KwaZulu Natal and the Eastern Cape
- Bayer remains committed to empower and enable smallholder farmers to be active participants in their local economy.

KwaZulu Natal (KZN), 11 July 2018 – The Umzimkhulu farming community’s wool production initiatives in KZN are set to to receive a major boost following today’s
handover of much-needed shearing equipment from Bayer in South Africa, one of four farming community’s that the project is being extended to for 2018. The remaining three
farming communities are based in the Eastern Cape and follows on Bayer’s initial equipment handover to four other shearing sheds, also in the Eastern Cape, at the end of
last year. Wool is one of the most profitable commodities in agriculture and most of it forms part of large exported agricultural items with reports suggesting that the industry
could add upto R2 billion to the GDP.1

Facilitated through a partnership with the local Department of Agriculture and Rural Development in both KZN and the Eastern Cape, the shearing equipment, maintenance of the shearing shed and training for the farming communities is a fulfillment of Bayer’s commitment to empower and enable smallholder farmers to be active participants in their local economy.

Dr György Polgár, Head of the Animal Health in Southern Africa explained the significance of the project to smallholder farming, “Having the correct equipment is critical to bolster efficiency and production volumes for smallholder farming communities that are already pooling their resources together. We believe that we have a responsibility to nagivate the 1 400 communal wool sheep producing communities in South Africa and identify those that really need our help to meet future demands that are perpetuated by a growing population. Through our partnership with government and local farming communities, we are hoping to help enhance efficiencies in order for the community farmers to increase productivity and become competitive.” Agriculture is an important source of employment with an estimated 990 000 households involved in livestock production2. An estimated 95 percent of the total farming community falls within the emerging farmers’ category and many lack the support and services needed so they can excel and succeed, underlining the significance of partnerships such as these. Dr Polgár concluded: “We are hoping that this support, in the form of time in services and maintenance in these operations, as well as our investment in the form of critical tools-of-the-trade will advance these emerging farmers. Most importantly, the sustenance of their operations guarantees much needed employment and the promotion of entrepreneurship.”

About Bayer
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.co.za
Contact:
Tasniem Patel
Mobile +27 82 8732423
Head of Communications for Southern Africa
Email: tasniem.patel@bayer.com
Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.